Nuvectis Pharma, Inc. - Common Stock —— 季度资产负债表 (NASDAQ:NVCT) | MetaTrader

展开完整图表完整图表

新闻

Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet

Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade

Nuvectis initiates phase 1b trial combining NXP900 with osimertinib

H.C. Wainwright重申Nuvectis Pharma股票评级为"买入"

Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright

卡普兰以64,240美元购入Nuvectis Pharma (NVCT)股票

Nuvectis Pharma董事长Bentsur购入价值28,600美元的股份

Nuvectis Pharma董事Sanchez以7.5万美元购入NVCT股票

H.C. Wainwright维持Nuvectis Pharma股票买入评级，目标价10美元

H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target

Nuvectis Pharma adds former Intra-Cellular exec to board of directors

Nuvectis initiates phase 1b program for cancer drug NXP900